US Stock MarketDetailed Quotes
STRM Streamline Health Solutions
- 3.390
- +0.240+7.62%
Close Dec 20 16:00 ET
- 3.220
- -0.170-5.01%
Post 16:42 ET
14.46MMarket Cap-1.44P/E (TTM)
3.480High3.070Low50.58KVolume3.070Open3.150Pre Close167.02KTurnover2.32%Turnover RatioLossP/E (Static)4.27MShares9.74752wk High1.04P/B7.41MFloat Cap1.85052wk Low--Dividend TTM2.18MShs Float130.500Historical High--Div YieldTTM13.02%Amplitude0.150Historical Low3.302Avg Price1Lot Size
Streamline Health Solutions Key Stats
Quarterly+Annual
YOY
| (Q3)Oct 31, 2024 | (Q2)Jul 31, 2024 | (Q1)Apr 30, 2024 | (FY)Jan 31, 2024 | (Q4)Jan 31, 2024 | (Q3)Oct 31, 2023 | (Q2)Jul 31, 2023 | (Q1)Apr 30, 2023 | (FY)Jan 31, 2023 | (Q4)Jan 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -43.51%-1.76M | 130.04%319K | -1,051.59%-1.2M | 68.99%-2.22M | 97.77%-54K | 30.79%-1.23M | 36.82%-1.06M | 109.92%126K | -83.91%-7.14M | -1,855.07%-2.42M |
| Net income from continuing operations | 79.21%-2.48M | -11.45%-2.8M | 5.58%-2.74M | -64.31%-18.7M | 37.21%-1.37M | -279.57%-11.91M | 23.14%-2.52M | -4.09%-2.9M | -64.51%-11.38M | -54,450.00%-2.18M |
| Depreciation and amortization | 15.40%1.3M | 8.84%1.17M | 5.76%1.12M | 0.42%4.33M | 2.50%1.07M | 5.31%1.13M | -1.92%1.08M | -3.99%1.06M | 16.66%4.31M | -30.27%1.04M |
| Deferred tax | --0 | --0 | --0 | -1,255.56%-104K | --0 | ---147K | --4K | --39K | -90.53%9K | --9K |
| Other non cash items | 115.31%181K | 173.82%265K | 148.35%176K | -2,638.03%-1.94M | -133.33%-39K | -625.15%-1.18M | -175.58%-359K | 27.20%-364K | 96.16%-71K | 104.44%117K |
| Change In working capital | -198.53%-1.22M | 518.37%1.21M | -114.82%-255K | 170.65%1.33M | 91.29%-178K | -320.62%-408K | 161.44%196K | 199.30%1.72M | -263.97%-1.88M | -420.72%-2.04M |
| -Change in receivables | 15.16%-582K | 44.52%1.57M | -99.56%17K | 188.24%3.71M | 87.41%-591K | -520.86%-686K | 7.75%1.09M | 675.22%3.9M | -3,157.36%-4.2M | -490.44%-4.69M |
| -Change in payables and accrued expense | -114.77%-151K | 304.81%426K | 62.30%-423K | -179.93%-733K | -424.43%-425K | 92.47%1.02M | 71.07%-208K | -215.20%-1.12M | 66.73%917K | 186.18%131K |
| -Change in other current assets | -155.56%-45K | 122.14%29K | -566.67%-100K | 66.50%-401K | -2.13%-336K | 164.29%81K | 82.53%-131K | -287.50%-15K | -245.95%-1.2M | -260.49%-329K |
| -Change in other working capital | 46.67%-440K | -47.45%-811K | 124.09%251K | -147.84%-1.24M | -58.79%1.17M | -24.06%-825K | -484.62%-550K | -484.50%-1.04M | 141.90%2.6M | 106.60%2.85M |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -43.51%-1.76M | 130.04%319K | -1,051.59%-1.2M | 68.99%-2.22M | 97.77%-54K | 30.79%-1.23M | 36.82%-1.06M | 109.92%126K | -103.85%-7.14M | -2,262.50%-2.42M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 55.04%-241K | 69.69%-194K | 46.42%-232K | 16.23%-1.62M | 97.55%-12K | 4.96%-536K | -76.80%-640K | 16.57%-433K | 85.31%-1.94M | 10.75%-490K |
| Capital expenditure reported | 55.04%-241K | 68.81%-194K | 42.57%-232K | 18.60%-1.57M | 98.98%-5K | 4.96%-536K | -76.70%-622K | 22.16%-404K | -32.03%-1.93M | -19.51%-490K |
| Net PPE purchase and sale | --0 | --0 | --0 | -440.00%-54K | ---7K | --0 | -80.00%-18K | ---29K | 75.61%-10K | --0 |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 55.04%-241K | 69.69%-194K | 46.42%-232K | 16.23%-1.62M | 97.55%-12K | 4.96%-536K | -76.80%-640K | 16.57%-433K | 85.31%-1.94M | 10.75%-490K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -438.96%-783K | -186.87%-568K | 830.26%2.22M | -92.61%428K | 131.93%699K | -97.15%231K | -3,400.00%-198K | -115.60%-304K | -76.02%5.79M | -2,416.09%-2.19M |
| Net issuance payments of debt | -654.40%-1.39M | -100.00%-250K | 2,220.00%2.65M | 400.00%750K | 700.00%750K | 300.00%250K | ---125K | ---125K | -102.50%-250K | ---125K |
| Net common stock issuance | --0 | --0 | --100K | --0 | --0 | --0 | --0 | --0 | -48.35%8.32M | --0 |
| Proceeds from stock option exercised by employees | --0 | 86.30%-10K | 62.57%-67K | -42.13%-280K | 71.88%-9K | 20.83%-19K | ---73K | -26.95%-179K | 57.54%-197K | 61.90%-32K |
| Net other financing activities | --603K | ---308K | ---463K | 97.98%-42K | ---- | ---- | ---- | ---- | -39.74%-2.08M | -67,633.33%-2.03M |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -438.96%-783K | -186.87%-568K | 830.26%2.22M | -92.61%428K | 131.93%699K | -97.15%231K | -3,400.00%-198K | -115.60%-304K | -76.02%5.79M | -2,416.09%-2.19M |
| Net cash flow | ||||||||||
| Beginning cash position | -13.48%3.54M | -33.54%3.98M | -51.65%3.19M | -33.25%6.6M | -78.14%2.56M | -30.94%4.09M | -24.74%5.99M | -33.25%6.6M | 310.34%9.89M | 12.39%11.7M |
| Current changes in cash | -81.83%-2.78M | 76.68%-443K | 229.13%789K | -3.68%-3.41M | 112.41%633K | -126.47%-1.53M | 6.73%-1.9M | 68.34%-611K | -143.97%-3.29M | -873.47%-5.1M |
| End cash Position | -70.51%754K | -13.48%3.54M | -33.54%3.98M | -51.65%3.19M | -51.65%3.19M | -78.14%2.56M | -30.94%4.09M | -24.74%5.99M | -33.25%6.6M | -33.25%6.6M |
| Free cash flow | -13.52%-2M | 107.34%125K | -366.12%-1.43M | 57.74%-3.84M | 97.73%-66K | 24.55%-1.76M | 16.69%-1.7M | 82.84%-307K | -81.45%-9.08M | -807.17%-2.91M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | -- | -- | -- | -- | -- | Unqualified Opinion | -- |
Heat List
US
Overall
Symbol
Price
% Chg
No Data